DIVIDEND ANNOUNCEMENT: Bristol Myers Squibb Co. (NYSE:BMY) on 12/08/2022 declared a dividend of $0.5700 per share

Bristol Myers Squibb Co. (NYSE:BMY) on 12/08/2022 declared a dividend of $ 0.5700 per share payable on February 01, 2023 to shareholders of record as of January 06, 2023. Dividend amount recorded is an increase of $ 0.03 from last dividend Paid.

Bristol Myers Squibb Co. (NYSE:BMY) has paid dividends since 1900, has a current dividend yield of 2.8524959087% and has increased its dividends for 12 successive years.

Bristol Myers Squibb Co.'s market cap is $ 169,943,968,800 and has a PE ratio of 0.00. The stock price closed yesterday at $ 79.93 and has a 52 week low/high of $ 56.11 and $ 81.43.

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.

For more information on Bristol Myers Squibb Co. click here.